Safety of the trivalent inactivated influenza vaccine among children: A population-based study

Archives of Pediatrics and Adolescent Medicine

Volumn 158, Issue 11, 2004, Pages 1031-1036

  France, Eric K ^a,d   Glanz, Jason M ^a   Xu, Stanley ^a   Davis, Robert L ^b,c,d   Black, Steven B ^d   Shinefield, Henry R ^d   Zangwill, Kenneth M ^e   Marcy, S Michael ^d   Mullooly, John P ^f   Jackson, Lisa A ^g   Chen, Robert ^b  

^a CLINICAL RESEARCH UNIT   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KAISER PERMANENTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; TRIVALENT INACTIVATED INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BRONCHIOLITIS; BRONCHITIS; CHILD; CHILDHOOD DISEASE; CHRONIC RHINITIS; CONSULTATION; CONTROLLED STUDY; CONVULSION; DERMATITIS; DIABETES MELLITUS; DRUG SAFETY; DYSPNEA; EMERGENCY TREATMENT; FEMALE; FEVER; FOLLOW UP; HEALTH MAINTENANCE ORGANIZATION; HOSPITAL CARE; HUMAN; IMPETIGO; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICALLY ATTENDED EVENT; OTITIS MEDIA; OUTPATIENT CARE; PNEUMONIA; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SINUSITIS; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; URETER DISEASE;

CASE-CONTROL STUDIES; CHILD; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INFANT; INFLUENZA VACCINES; MALE; MEDICAL RECORD LINKAGE; POPULATION SURVEILLANCE; UNITED STATES;

EID: 7644232069     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.158.11.1031     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Update: Influenza activity-United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine. JAMA. 2001;286:36-38.
2. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratoiy disease among infants and young children. N Engl J Med. 2000;342:232-239.
3. Neuzil KM, Mellen BF, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-231.
4. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arala M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. AJDC. 1991;145:445-448.
5. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6-to-30-month-old children in daycare. Arch Pediatr Adolesc Med. 1995;149:1113-1117.
6. Hurwitz ES, Haber M, Chang A, et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending daycare: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis. 2000;182:1218-1221.
7. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J. 2001;20:733-740.
8. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004;23:189-200.
9. Black SB, Shinefield HR, Ray P, et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr Infect Dis J. 1999;18:1041-1046.
10. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine: United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 1999;48:577-581.
11. Maclure M. The case-crossover design: a method for studying transient effects on risk of acute events. Am J Epidemiol. 1991;133:144-153.
12. Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Datalink Project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99:765-773.
13. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1-7.
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
15. Grobbee DE, Hoes AW. Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ. 1997;315:1151-1154.
16. 2-receptor antagonists, and gastric cancer. Epidemiology. 1997;8:335.
17. Kramarz P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine. 2000;18:2288-2294.
18. Kramarz P, DeStefano F, Frank MD, et al. Does influenza vaccination exacerbate asthma? analysis of a large cohort of children with asthma. Arch Fam Med. 2000;9:617-623.
19. Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr. 2001;138:306-310.
20. Gaglani M, Riggs M, Kamenicky C, Glezen P. A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease. Pediatr Infect Dis J. 2001;20:1155-1160.
21. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995;51:228-235.
22. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996;143:1165-1173.
23. Liang KY. Extended Mantel-Haenszel estimating procedure for multivariate logistic regressions. Biometrics. 1987;43:289-300.